FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3396701000001105: Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    7158001000001117 Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    8922701000001113 Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Is a Product containing papaveretum and scopolamine hydrobromide false Inferred relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Availability Discontinued product false Additional relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Legal category Controlled Drug false Additional relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Product name type Generic name false Additional relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Has active ingredient Opium false Inferred relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Has active ingredient Central nervous system agent false Inferred relationship Existential restriction modifier
    Papaveretum+hyoscine 7.7mg/400micrograms/1mL injection Has active ingredient Papaveretum false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start